Oury Medical specializes in manufacturing orthopedic and spinal surgical instruments and implants and has grown through a series of targeted acquisitions since 2022. The group reports more than €25 million in revenue and employs nearly 200 people across five production sites following its latest acquisition of Céfiméca. Oury Medical’s recent fundraising of over €30 million was used to acquire Céfiméca and support planned industrial investments to optimize production. The company expanded rapidly from €5 million in revenue in 2022 to over €25 million by 2025, driven by acquisitions and investments in production and operational efficiency. Backed by Tag Partners (majority investor since 2022) and new investor Isalt (via the FST), Oury Medical intends to pursue further targeted purchases to consolidate its position on major global markets and aim to become a leading European player in orthopedics and spine surgery.

Total raised

$35M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2026